CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 51 enrolled
Drug / intervention
ADHD methylphenidate first, placebo second +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02630017
NCT02630017Phase 2Completed

Motivated Behavior in Adults With and Without ADHD

University of Arkansas·interventional·Posted Dec 15, 2015·Updated Aug 27, 2021

In Brief

A Phase 2 clinical trial evaluating ADHD methylphenidate first, placebo second, ADHD placebo first, methylphenidate second, and 2 other interventions for ADHD. Completed, enrolled 51 participants across 2 sites.

Detailed Summary

To investigate the effects of methylphenidate on motivated behavior in adults with and without ADHD

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsADHD
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 15, 2015
Enrollment StartMar 7, 2016
Primary CompletionSep 21, 2018
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 10.5 years ago

Interventions

ADHD methylphenidate first, placebo seconddrug

double-blind, counter-balanced administration

ADHD placebo first, methylphenidate seconddrug

double-blind, counter-balanced administration

Non-ADHD methylphenidate first, placebo seconddrug

double-blind, counter-balanced administration

Non-ADHD placebo first, methylphenidate seconddrug